A central question facing ICER and CVS Caremark is whether a drug’s value should depend on not only a measure such as QALYs, but also on which disease or population is being treated, which implies that a QALY may not always have the same weight.
Category: Forbes
It’s Not About What You Know. Soft Skills Are Hard
Cultivating and reinforcing what makes us human is the ticket and in the process, we must stop referring to those skills and attributes as “soft” as they are the only thing that’s -still- hard for the competition.